Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
02/25/2010 | US20100048633 Piperidine-4-acrylamides |
02/25/2010 | US20100048623 Piperidines and related compounds for the treatment of alzheimer's disease |
02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
02/25/2010 | US20100048550 Selective tr-beta 1 agonist |
02/25/2010 | US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
02/25/2010 | US20100048545 Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity |
02/24/2010 | EP2157083A2 Pharmaceutical compositions containing crystalline form (I) of lercanidipine hydrochloride |
02/24/2010 | EP2155679A2 Method for the production of 4-formylaminopiperidine derivatives |
02/24/2010 | EP2155678A1 New bradykinin b1 antagonists |
02/24/2010 | EP2155677A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase |
02/24/2010 | EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
02/24/2010 | EP2155659A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
02/24/2010 | EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
02/24/2010 | CN101654429A Method for obtaining S-(-)-amlodipine in splitting manner |
02/24/2010 | CN101654428A Method for extracting and separating 1-deoxynojirimycin with high purity from natural products |
02/24/2010 | CN100591670C Levamlodipine besylate production method |
02/24/2010 | CN100591669C Amlodipine gentisate and a method of its preparation |
02/23/2010 | US7667046 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
02/23/2010 | US7666881 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride formed by azeotropic distillation |
02/23/2010 | US7666866 Antithrombotic diamides |
02/23/2010 | US7666865 Calcium channel blockers |
02/23/2010 | CA2341791C 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides |
02/23/2010 | CA2335461C Calcium channel blockers |
02/18/2010 | WO2010019560A1 Deuterated derivatives of donepezil |
02/18/2010 | US20100041893 Formation of tetra-substituted enamides and stereoselective reduction thereof |
02/18/2010 | US20100041892 Therapeutic agent for diabetes |
02/18/2010 | US20100041704 Dermal compositions of substituted amides and the use thereof as medication for pain and pruritus |
02/18/2010 | US20100041702 Benzimidazole cannabinoid agonists |
02/18/2010 | US20100041701 Biphenyl compounds useful as muscarinic receptor antagonists |
02/18/2010 | US20100041667 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
02/18/2010 | US20100041658 Hydroxyphenyl Derivatives and Biological Applications Thereof |
02/17/2010 | EP2152710A2 4,4-disubstituted piperidine derivatives |
02/17/2010 | EP2152265A1 New method for preparing isofagomine and its derivatives |
02/17/2010 | EP2152074A1 Compositions of (-)-e-10-oh-nt and methods for their synthesis and use |
02/17/2010 | EP1978919B1 Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions |
02/17/2010 | EP1420775B1 Platinum complexes and their uses in therapy |
02/17/2010 | CN101648941A 4-tetrazolyl-4phenylpiperidine derivatives for treating pain |
02/17/2010 | CN101648903A Method for preparing optically active amlodipine tosilate |
02/17/2010 | CN101648902A Dihydropyridine type tumor chemotherapeutic sensitizer and application thereof |
02/16/2010 | US7662967 3-(2',2'-Dimethylpropanoylamino)tetrahydropyridin-2-one for prevention or treatment of inflammatory disorders, autoimmune diseases |
02/16/2010 | US7662966 For example, 5-tert-Butyl-2-{2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-1H-benzoimidazole; use in leukocyte recruitment inhibition, in modulating H4 receptor, and in treating conditions such as inflammation, H4 receptor-mediated conditions, and related conditions |
02/16/2010 | US7662965 Anabaseine derivatives, pharmaceutical compositions and method of use thereof |
02/16/2010 | US7662964 Reacting 4-piperidino-piperidine with phosgene in methylene chloride; reduced dimers formed; intermediate for irinotecan |
02/16/2010 | US7662849 N-cyanomethyl-2R-[(benzenesulfonyliminomethyl)amino]-3-(2-difluoromethoxyphenylmethanesulfonyl)-propionamide; treating autoimmune disorders |
02/16/2010 | US7662838 containing N-(5-adamantane-1-yl-methoxy-pentyl)- group; for treatment of insulin resistance, hyperpigmentation and/or inflammatory processes in skin, fungal disease, overweight and obesity, or microbacterial infection |
02/16/2010 | US7662835 Methods of treating allergic reactions using an anhydrous form of antihistaminic piperidine derivatives |
02/16/2010 | US7662828 Substituted 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2-yl compounds and 5,6,7,8-tetrahydroquinazoline-2-yl compounds |
02/16/2010 | US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease |
02/16/2010 | US7662812 disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances |
02/16/2010 | CA2478183C Substituted amides |
02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
02/16/2010 | CA2442882C Sulphones which modulate the action of gamma-secretase |
02/16/2010 | CA2410939C Materials and methods for the treatment of gastroesophageal reflux disease |
02/16/2010 | CA2385938C Cyclic amine compounds as ccr5 antagonists |
02/11/2010 | WO2010017343A2 Flupirtine hydrochloride maleic acid cocrystal |
02/11/2010 | WO2010017135A2 Novel forms of eperisone |
02/11/2010 | WO2010017060A1 Urea derivatives as antibacterial agents |
02/11/2010 | WO2010016554A1 Cyclic amine compound |
02/11/2010 | WO2010015816A2 Treatment of lysosomal storage disorders and other proteostatic diseases |
02/11/2010 | US20100036125 Synthesis of ccr5 receptor antagonists |
02/11/2010 | US20100036119 Fluorinating reagents and their preparation |
02/11/2010 | US20100036084 Biodegradable poly(beta-amino esters) and uses thereof |
02/11/2010 | US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
02/11/2010 | US20100035928 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate |
02/11/2010 | US20100035924 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
02/11/2010 | US20100035879 N-sulfonylcarboximidamide apoptosis promoters |
02/11/2010 | US20100035869 Targeted nitroxide agents |
02/11/2010 | US20100035865 Sulfonamides and Pharmaceutical Compositions Thereof |
02/11/2010 | US20100035279 Fluorescent Substrates for Monoamine Transporters as Optical False Neurotransmitters |
02/11/2010 | US20100034813 Substituted pyrazole and triazole compounds as ksp inhibitors |
02/11/2010 | CA2738866A1 Flupirtine hydrochloride maleic acid cocrystal |
02/11/2010 | CA2732045A1 Urea derivatives as antibacterial agents |
02/10/2010 | EP2150620A2 Method for preparing c-6 phosphorylated d-aldohexoses and c-6 phosphorylated d-aldohexose derivatives, and new c-6 phosphorylated d-aldohexose derivatives |
02/10/2010 | EP2150530A1 Substituted sulfonamide derivatives |
02/10/2010 | EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors |
02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
02/10/2010 | EP1701951B1 Modulators of peripheral 5-ht receptors |
02/09/2010 | US7659403 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-(2-[methyl(3-(2-[(thiophen-2-ylmethyl)amino]ethylcarbamoyl)benzoyl)amino]ethyl)piperidin-4-yl ester |
02/09/2010 | US7659402 use as pain relievers, gastrointestinal disorders; 2-Amino-3-aryl-1-[3-((hetero)aryl)piperidin-1-yl]-propan-1-one compounds |
02/09/2010 | US7659287 Benzamide derivatives and uses related thereto |
02/09/2010 | US7659285 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
02/09/2010 | CA2430673C N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
02/09/2010 | CA2413061C Serine protease inhibitors |
02/09/2010 | CA2299754C Hydroxy-substituted n-alkoxy hindered amines |
02/09/2010 | CA2274201C Di-or triaza-spiro[4,5]decane derivatives |
02/09/2010 | CA2218369C Transdermal electrotransport delivery of fentanyl and sufentanil |
02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
02/04/2010 | WO2010014933A2 Psma-binding agents and uses thereof |
02/04/2010 | WO2010014573A1 Anti-malarial compounds |
02/04/2010 | WO2010012964A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
02/04/2010 | US20100029720 Carboxamide Derivatives As Muscarinic Receptor Antagonists |
02/04/2010 | US20100029687 Piperidine derivative or salt thereof |
02/04/2010 | US20100029670 Organic compounds |
02/04/2010 | US20100029647 3,4,(5)-substituted tetrahydrophyridines |
02/04/2010 | US20100025661 Luminescent material and organic electroluminescent device using the same |
02/04/2010 | CA2732632A1 Psma-binding agents and uses thereof |
02/04/2010 | CA2732572A1 Anti-malarial compounds |